Skip to main content
. 2023 Feb 13;13:2502. doi: 10.1038/s41598-023-29006-z

Figure 4.

Figure 4

Kaplan–Meier analysis of the (A) target lesion revascularization and (B) all-cause mortality. There were no differences in the target lesion revascularization or all-cause mortality between the sarpogrelate group and the clopidogrel group according to the logistic regression analysis.